Discovery of benzimidazole-diamide finger loop (Thumb Pocket I) allosteric inhibitors of HCV NS5B polymerase: Implementing parallel synthesis for rapid linker optimization

被引:23
作者
Goulet, Sylvie [1 ]
Poupart, Marc-Andre [1 ]
Gillard, James [1 ]
Poirier, Martin [1 ]
Kukolj, George [1 ]
Beaulieu, Pierre L. [1 ]
机构
[1] Boehringer Ingelheim Canada Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada
关键词
Hepatitis C virus; HCV; NS5B polymerase; Inhibition; Allosteric inhibitors; Replicon; Replication; NONNUCLEOSIDE INHIBITORS; HCVNS5B POLYMERASE; HEPATITIS; REPLICONS;
D O I
10.1016/j.bmcl.2009.10.136
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Previously described SAR of benzimidazole-based non-nucleoside finger loop (Thumb Pocket I) inhibitors of HCV NS5B polymerase was expanded. Prospecting studies using parallel synthesis techniques allowed the rapid identification of novel cinnamic acid right-hand sides that provide renewed opportunities for further optimization of these inhibitors. Novel diamide derivatives such as 44 exhibited comparable potency (enzymatic and cell-based HCV replicon) as previously described tryptophan-based inhibitors but physicochemical properties (e. g., aqueous solubility and lipophilicity) have been improved, resulting in molecules with reduced off-target liabilities (CYP inhibition) and increased metabolic stability. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:196 / 200
页数:5
相关论文
共 19 条
[1]  
Beaulieu P. L., 2003, WO Patent WO, Patent No. [03/010141, 03010141]
[2]   Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCVNS5B polymerase:: From benzimidazole to indole scaffolds [J].
Beaulieu, Pierre L. ;
Gillard, James ;
Bykowski, Darren ;
Brochu, Christian ;
Dansereau, Nathalie ;
Duceppe, Jean-Simon ;
Haché, Bruno ;
Jakalian, Araz ;
Lagacé, Lisette ;
LaPlante, Steven ;
McKercher, Ginette ;
Moreau, Elaine ;
Perreault, Stphane ;
Stammers, Timothy ;
Thauvette, Louise ;
Warrington, Jeff ;
Kukolj, George .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (19) :4987-4993
[3]  
Beaulieu PL, 2006, CURR OPIN DRUG DISC, V9, P618
[4]   Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection [J].
Beaulieu, Pierre L. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (02) :145-164
[5]   Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: Inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells [J].
Beaulieu, PL ;
Bousquet, Y ;
Gauthier, J ;
Gillard, J ;
Marquis, M ;
McKercher, G ;
Pellerin, C ;
Valois, S ;
Kukolj, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) :6884-6892
[6]   Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase:: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency [J].
Beaulieu, PL ;
Bös, M ;
Bousquet, Y ;
DeRoy, P ;
Fazal, G ;
Gauthier, J ;
Gillard, J ;
Goulet, S ;
McKercher, G ;
Poupart, MA ;
Valois, S ;
Kukolj, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) :967-971
[7]   Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase:: discovery and preliminary SAR of benzimidazole derivatives [J].
Beaulieu, PL ;
Bös, M ;
Bousquet, Y ;
Fazal, G ;
Gauthier, J ;
Gillard, J ;
Goulet, S ;
LaPlante, S ;
Poupart, MA ;
Lefebvre, S ;
McKercher, G ;
Pellerin, C ;
Austel, V ;
Kukolj, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) :119-124
[8]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[9]   Challenges and successes in developing new therapies for hepatitis C [J].
De Francesco, R ;
Migliaccio, G .
NATURE, 2005, 436 (7053) :953-960
[10]   Optimal therapy in genotype 1 patients [J].
Farnik, Harald ;
Mihm, Ulrike ;
Zeuzem, Stefan .
LIVER INTERNATIONAL, 2009, 29 :23-30